Literature DB >> 28576593

Impact of Omission of Intrapulmonary Lymph Node Retrieval on Outcome Evaluation of Lung Cancer Patients Without Lymph Node Metastasis: A Propensity Score Matching Analysis.

Xing Wang1, Shi Yan1, Chao Lv1, Yuzhao Wang1, Jia Wang1, Shaolei Li1, Lijian Zhang1, Yue Yang1, Nan Wu2.   

Abstract

INTRODUCTION: Clinical practice of retrieval of segmental (station 13) and subsegmental (station 14) lymph nodes for pathologic examination varies during lung cancer surgery. This study aimed to evaluate whether omitting retrieval of nodes from stations 13 and 14 could affect outcome evaluation for patients with pN0 non-small-cell lung cancer (NSCLC).
METHODS: This retrospective study analyzed 442 patients with NSCLC who were treated with both R0 resection and systematic mediastinal lymphadenectomy with pathologically confirmed stage pN0 NSCLC. The study group included patients in whom N1 nodes including stations 10 to 14 were investigated, and the control group included patients in whom stations 10 to 12 only were investigated. Clinical and pathologic parameters of the groups were balanced by propensity score matching, and oncologic outcomes were assessed by the log-rank test.
RESULTS: A total of 435 cases were included in the final analysis (170 in the study group and 265 in the control group). In the study group, a mean ± SD of 5.0 ± 3.0 nodes per case were collected from nodes 13 and 14. After propensity score matching, 143 cases were included in each group. Overall and disease-free survival improved in the study group compared to the control group (P = .027 and P = .021, respectively). T staging and intrapulmonary node collection were prognostic factors for pN0 cases.
CONCLUSION: Inferior oncologic outcomes of pN0 cases without intrapulmonary node retrieval suggest that the procedure of intrapulmonary lymph node retrieval may play a role in outcome evaluation for pN0 NSCLC patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lymph node; NSCLC; Pathologic staging; Prognosis; Segmental; Subsegmental

Mesh:

Year:  2017        PMID: 28576593     DOI: 10.1016/j.cllc.2017.05.001

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


  14 in total

1.  Perspective and clinical relevance of intrapulmonary lymph node retrieval: response to the editorial by Tantraworasin and colleagues and the editorial by Marc Riquet and colleagues.

Authors:  Nan Wu; Xing Wang; Yaqi Wang; Shi Yan
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

2.  Role of intrapulmonary lymph node retrieval for pathological examination in resectable non-small cell lung cancer.

Authors:  Apichat Tantraworasin; Emanuela Taioli; Sophon Siwachat; Somcharoen Saeteng
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  Pathologic N1 disease in lung cancer: the segmental and subsegmental lymph nodes.

Authors:  Marc Riquet; Ciprian Pricopi; Giuseppe Mangiameli; Alex Arame; Alain Badia; Françoise Le Pimpec Barthes
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

4.  Spanish Lung Cancer Group SCAT trial: surgical audit to lymph node assessment based on IASLC recommendations.

Authors:  José Ramón Jarabo Sarceda; Sergio Bolufer Nadal; Roberto Mongil Poce; Pedro López de Castro; Ramón Moreno Balsalobre; Juan Carlos Peñalver Cuesta; Raul Embún Flor; Joaquín Pac Ferrer; Francisco Javier Algar Algar; Antonio Pablo Gámez García; Marcelo F Jiménez; Jesús Gabriel Sales-Badía; Eva Pereira; Bartomeu Massuti; Mariano Provencio; Florentino Hernando Trancho
Journal:  Transl Lung Cancer Res       Date:  2021-04

5.  Skip metastasis in mediastinal lymph node is a favorable prognostic factor in N2 lung cancer patients: a meta-analysis.

Authors:  Zihuai Wang; Jiahan Cheng; Wenyu Huang; Diou Cheng; Yilin Liu; Qiang Pu; Nathan E Reticker-Flynn; Lunxu Liu
Journal:  Ann Transl Med       Date:  2021-02

6.  Value of N1 Lymph Node Examination in the Prognosis of Patients With pT1-3N0M0 Non-Small Cell Lung Cancer.

Authors:  Gaoxiang Wang; Xianning Wu; Xiaohui Sun; Tian Li; Meiqing Xu; Liangdong Xu; Mingran Xie
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

7.  The impact of an N1 lymph node examination in patients with early-stage non-small cell lung cancer: a retrospective cohort study.

Authors:  Wenyu Zhai; Yuzhen Zheng; Yuming Rong; Xiaoqiang Li; Qihang Yan; Fangfang Duan; Zerui Zhao; Jianlong Chen; Shuqin Dai; Junye Wang
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

8.  Adjuvant chemotherapy may improve outcome of patients with non-small-cell lung cancer with metastasis of intrapulmonary lymph nodes after systematic dissection of N1 nodes.

Authors:  Xing Wang; Shi Yan; Yaqi Wang; Xiang Li; Chao Lyu; Yuzhao Wang; Jia Wang; Shaolei Li; Lijian Zhang; Yue Yang; Nan Wu
Journal:  Chin J Cancer Res       Date:  2018-12       Impact factor: 5.087

9.  Intrapulmonary lymph node (stations 13 and 14) metastasis in peripheral non-small cell lung cancer.

Authors:  Lei Bi; Hong Zhang; Mingjian Ge; Zhongzhu Lv; Yiping Deng; Tenghao Rong; Chaolun Liu
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

10.  Analysis of Segmental Lymph Node Metastasis and Clinical Features in cT1N0M0 Lung Adenocarcinoma.

Authors:  Guanghao Sun; Yanbin Sun; Zifang Zou; Shun Xu
Journal:  Biomed Res Int       Date:  2020-02-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.